Concord Drugs Limited, founded in 1995, is a prominent pharmaceutical company in India known for manufacturing a variety of Finished Pharmaceutical Formulations, including injectables, tablets, capsules, and ophthalmic preparations. The company operates two advanced manufacturing facilities licensed by the Government of Andhra Pradesh, featuring state-of-the-art technology for producing Liquid Injections, Dry Powder Injections, and Ready-to-fill Pellets, ensuring high process integrity and quality.
Initially focused on Finished Pharmaceutical Formulations, Concord Drugs has expanded into Ready-to-fill Pellets and offers end-to-end pharmaceutical solutions through contract manufacturing. The company is also involved in developing innovative drug delivery systems such as MUPS (Multiple Unit Pellet System), Sustained Release, and Modified Release pellets. Concord Drugs operates a cGMP-certified contract manufacturing facility providing comprehensive pharmaceutical development and manufacturing services, leveraging modern processing machinery to deliver cutting-edge pharmaceutical products.
